| PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF-P27037-K1A | -1.0 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | No_ligand | No_ligand | 184 - 489 | 0 | None | None | Activin receptor type-2A |
| AF-P27037-K3A | -1.0 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | No_ligand | No_ligand | 184 - 489 | 0 | None | None | Activin receptor type-2A |
| 3Q4TB | 1.96 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | TAK | Type1 | 191 - 485 | 0 | None | None | Activin receptor type-2A |
| 3SOCB | 1.95 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | GVD | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A |
| 4ASXA | 2.05 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | 6OJ | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A |
| 3Q4TA | 1.96 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | TAK | Type1 | 191 - 484 | 0 | None | None | Activin receptor type-2A |
| 3SOCA | 1.95 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | GVD | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A |
| 4ASXB | 2.05 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | 6OJ | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A |
| UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVR2A_HUMAN | AF-P27037-K1A | -1.0 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | No_ligand | No_ligand | 184 - 489 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | AF-P27037-K3A | -1.0 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | No_ligand | No_ligand | 184 - 489 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 3Q4TB | 1.96 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | TAK | Type1 | 191 - 485 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 3SOCB | 1.95 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | GVD | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 4ASXA | 2.05 | Active | DFGin‑BLAminus | in-in | in-in | nonTYR | APEdihe_aaiii | APEdist_iiii | 6OJ | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 3Q4TA | 1.96 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | TAK | Type1 | 191 - 484 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 3SOCA | 1.95 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | GVD | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| AVR2A_HUMAN | 4ASXB | 2.05 | Inactive | DFGin‑BLAminus | in-in | in-out | nonTYR | APEdihe_aaiii | APEdist_iooi | 6OJ | Type1 | 191 - 486 | 0 | None | None | Activin receptor type-2A | Homo sapiens |
| Spatial label | Dihedral label | Number of Chains | Percent | Representative |
|---|
| UniprotID | PDB | Resolution | Activity | Spatial-Dihedral | Chelix-SaltBridge | ActLoopNT-ActLoopCT | APEtype | APEdihe | APEdist | Ligand | Ligand Type | Residues in structure | Unresolved residues in A-loop | Phosphorylation | Mutation | Protein | Organism |
|---|